XML 25 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital Amount
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance (in shares) at Dec. 31, 2015   42,984,243      
Balance at Dec. 31, 2015 $ 461,285 $ 4 $ 907,040 $ 5 $ (445,764)
Increase (Decrease) in Stockholders' Equity          
Net loss (182,804)       (182,804)
Unrealized gain (loss) from available-for-sale securities 66     66  
Exercise of warrants (in shares)   19,172      
Exercise of options (in shares)   137,719      
Exercise of options 2,573   2,573    
Share-based compensation expense 26,058   26,058    
Balance (in shares) at Dec. 31, 2016   43,141,134      
Balance at Dec. 31, 2016 307,178 $ 4 935,671 71 (628,568)
Increase (Decrease) in Stockholders' Equity          
Net loss (254,237)       (254,237)
Unrealized gain (loss) from available-for-sale securities (385)     (385)  
Exercise of options (in shares)   1,385,120      
Exercise of options 17,477   17,477    
Share-based compensation expense 33,839   33,839    
Vesting of restricted shares (in shares)   14,052      
Share-based compensation expense related to share-based awards for employee stock purchase plan 1,164   1,164    
Issuance of common stock upon purchase by employee stock purchase plan (in shares)   76,280      
Issuance of common stock upon purchase by employee stock purchase plan 2,550   2,550    
Equity component of 2024 Notes 138,707   138,707    
Equity component of deferred financing costs for 2024 Notes (4,257)   (4,257)    
Balance (in shares) at Dec. 31, 2017   44,616,586.000      
Balance at Dec. 31, 2017 242,036 $ 4 1,124,630 (314) (882,284)
Increase (Decrease) in Stockholders' Equity          
Net loss (221,337)       (221,337)
Unrealized gain (loss) from available-for-sale securities (441)     (441)  
Exercise of warrants (in shares)   336,059      
Exercise of options (in shares)   472,374      
Exercise of options 9,107 $ 1 9,106    
Share-based compensation expense 27,905   27,905    
Vesting of restricted shares (in shares)   36,852      
Vesting of restricted shares 0        
Share-based compensation expense related to share-based awards for employee stock purchase plan 796   796    
Issuance of common stock upon purchase by employee stock purchase plan (in shares)   101,822      
Issuance of common stock upon purchase by employee stock purchase plan 2,566   2,566    
Balance (in shares) at Dec. 31, 2018   45,563,693.000      
Balance at Dec. 31, 2018 $ 60,632 $ 5 $ 1,165,003 $ (755) $ (1,103,621)